MEDICINAL RESEARCH REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2025-01-09 1771ed158bm 来自江苏省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：农药学;天然产物化学;药物花絮
经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。
Accepted On 5 August 2024 by Editorial Office
Submitted On 4 April 2024

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2024-12-12 a201061519 来自河南省

有没有投稿的亲过来讨论下啊啊啊啊啊啊

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2023-11-15 ms7000000641553583 来自浙江省

偏重的研究方向：极低出生体重儿;危重新生儿
经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。

168 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2024-12-10 a201061519 来自河南省

最近有投稿的吗

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2023-02-27 ms5000000402047516 来自福建省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。
时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。

114 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2024-06-02 ms2000000925164052 来自山东省

无

63 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2024-01-31 ms1000001914122188 来自上海

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：新技术药物发现
经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。

79 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2023-12-23 1250d11bm60(暂无昵称) 来自浙江省

这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧

119 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2023-11-05 ms9000000677406404 来自辽宁省

审稿速度:24.0 | 投稿命中率:5.0
经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2247324, encodeId=50f6224e324ec, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：农药学;天然产物化学;药物花絮 经验分享：非常棒的一次投稿体验！自己陆续花了几年整理的天然产物方向的一个综述，学生也花了大半年撰写和修改，编辑和审稿人都很nice，给了很多中肯的修改意见，的确对论文提高有很大帮助。改了两轮就接受了，前后历时四个月。 Accepted On 5 August 2024 by Editorial Office Submitted On 4 April 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53ae2057240, createdName=1771ed158bm, createdTime=Thu Jan 09 21:17:10 CST 2025, time=2025-01-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2242128, encodeId=8d0022421283e, content=有没有投稿的亲过来讨论下啊啊啊啊啊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Thu Dec 12 21:20:13 CST 2024, time=2024-12-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2168574, encodeId=ca2f21685e4f4, content=偏重的研究方向：极低出生体重儿;危重新生儿 经验分享：2月9号投的稿子，到现在还在under review状态，也不知到有没有送审。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91d29058816, createdName=ms7000000641553583, createdTime=Wed Nov 15 00:07:43 CST 2023, time=2023-11-15, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241747, encodeId=b6a02241e4723, content=最近有投稿的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Tue Dec 10 23:01:05 CST 2024, time=2024-12-10, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116737, encodeId=379b2116e37c6, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：今天有消息了，刚好9个月，告诉我他们期刊这几年审稿压力很大，稿件量是三倍，还是没办法保证我的审稿，让我转投一个4分的期刊。大家慎重考虑此刊吧。 时间：投稿是2022年5月26日，在三个月、半年的时候分别催稿，第二次催稿回复我说文章正在外审，现在第9个月告诉我审不了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2745723606, createdName=ms5000000402047516, createdTime=Mon Feb 27 17:17:20 CST 2023, time=2023-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2207938, encodeId=2415220e93815, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4379181803, createdName=ms2000000925164052, createdTime=Sun Jun 02 17:20:09 CST 2024, time=2024-06-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2185059, encodeId=35c421850593f, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：新技术药物发现 经验分享：非常漫长的审稿，没有审稿人，稿件太多。影响因子还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58426528906, createdName=ms1000001914122188, createdTime=Wed Jan 31 17:03:05 CST 2024, time=2024-01-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2176673, encodeId=d17221e667334, content=这个杂志的确是个巨水坑，投了1年居然说不符合SCOPE。没有什么可说，提醒后来人吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08ec2535111, createdName=1250d11bm60(暂无昵称), createdTime=Sat Dec 23 11:13:22 CST 2023, time=2023-12-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2166807, encodeId=87b1216680e85, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：这个杂志真的恶心，投稿1年，中途写了4次催稿信，前两次都说没找到审稿人，第3次说已经找到审稿人了，正在等待编辑决定，第4次（在第3次后的1个月）再写催稿信，杂志终于给拒了，说没找到合适的审稿人，只能说这种杂志是真的恶心，如果一开始找不到直接给拒了多好，非常耽误时间，建议大家慎投！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=437c5555584, createdName=ms9000000677406404, createdTime=Sun Nov 05 15:10:29 CST 2023, time=2023-11-05, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2140610, encodeId=76cf214061019, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：心血管 经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4e875572837, createdName=ms7000000342226604, createdTime=Sat Jun 03 10:46:59 CST 2023, time=2023-06-03, status=1, ipAttribution=广东省)]

2023-06-03 ms7000000342226604 来自广东省

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：心血管
经验分享：投稿9个多月，中间催稿三次，最后拒稿，说稿量太大，处理不过来，真是无语。搞不懂为何不早点拒稿，浪费别人时间，不建议投此期刊。

151 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务